New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer (Q31440627)

2 July 2017

title

New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer (English)

1 reference

2 July 2017

A H Van Hattum

1

1 reference

2 July 2017

H M Pinedo

2

1 reference

2 July 2017

H M Schlüper

3

1 reference

2 July 2017

F H Hausheer

4

1 reference

2 July 2017

E Boven

5

1 reference

2 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

International Journal of Cancer

2 July 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

2 July 2017

volume

88

1 reference

2 July 2017

issue

2

1 reference

2 July 2017

page(s)

260-266

1 reference

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

2 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C260%3A%3AAID-IJC18%3E3.0.CO%3B2-Q

The bioavailability of oral GI147211 (GG211), a new topoisomerase I inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C260%3A%3AAID-IJC18%3E3.0.CO%3B2-Q

Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C260%3A%3AAID-IJC18%3E3.0.CO%3B2-Q

Major vault protein LRP-related multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C260%3A%3AAID-IJC18%3E3.0.CO%3B2-Q

CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C260%3A%3AAID-IJC18%3E3.0.CO%3B2-Q

DNA topoisomerase poisons as antitumor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C260%3A%3AAID-IJC18%3E3.0.CO%3B2-Q

Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C260%3A%3AAID-IJC18%3E3.0.CO%3B2-Q

Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C260%3A%3AAID-IJC18%3E3.0.CO%3B2-Q

CPT-11 Converting Enzyme from Rat Serum: Purification and Some Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C260%3A%3AAID-IJC18%3E3.0.CO%3B2-Q

Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C260%3A%3AAID-IJC18%3E3.0.CO%3B2-Q

Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001015%2988%3A2%3C260%3A%3AAID-IJC18%3E3.0.CO%3B2-Q

10.1002/1097-0215(20001015)88:2<260::AID-IJC18>3.0.CO;2-Q

21 January 2018

Identifiers

DOI

1 reference

2 July 2017

1 reference